Way Towards New Life

Breast Cancer Medications

Alleviare promptly facilitates Indian patients and physicians under Named Patient Programs (NPP) to access imported authorized medicines that are not locally available to them.

Get access to an unapproved drug that are used to treat thyroid cancer in patients for personal use.

Here is a list of some of the Anti-Cancer Drugs for Breast Cancer for which we currently have a NPP in place. If you are a patient or  healthcare professional, please click below on each to access details and information.

ENHERTU (fam-trastuzumab deruxtecan-nxki) for injection

A targeted therapy. Fam-Trastuzumab Deruxtecan-nxki injection are used to treat HER2-low breast cancer in patients.

KISQALI (ribociclib) tablets

It is approved to treat patients whose cancer has a certain mutation in the BRAF gene, including: Erdheim-Chester disease, Melanoma.

TRODELVY (sacituzumab govitecan-hziy) for injection

Rucaparib camsylate is approved to treat: Ovarian epithelial, fallopian tube, or primary peritoneal cancer, Prostate cancer.

TUKYSA (tucatinib) tablets

Indicated for the treatment of adult patients with relapsed or refractory advanced renal cell carcinoma (RCC) following

For Indian Patient Enquiry under NPP.

For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.

Query Form

We would love to speak with you.
Feel free to reach out using the below details.

Access Unauthorized Medicines In India Under NPP.

What is Named-patient access programme (NPP)?

Named-patient basis access can also refer to a medicine for a specific patient or patients that is not (yet) authorised and available to them in their own country. Such medicine should or must (depending on legislation) be authorised in at least one country, from which it can be imported into the patient’s country under a Named-patient access programme (NPP).

These may be medicines that are:

  • Authorised but not yet available to be prescribed in the patient’s country.
  • Authorised and available in one country but not authorised and available in the patient’s country.
  • Discontinued in the patient’s country but not in another country.
  • In shortage in the patient’s country but not in another country.






Hepatitis C

Hematologic Cancers


Immunological Disorders

Liver Disease

Multiple Sclerosis

Nerver Disease


Parkinson's Disease

Rare Disease

Soft Tissue Sarcoma


Specialty Drugs

Get Access to an Unapproved Drug

Get access to an unapproved drug for personal use to following cities in India – Ahmedabad, Aizawal, Aurangabad, Barshi, Bengaluru, Bhopal, Cachar, Chennai, Dibrugarh, Hyderabad, Karungapally, Kohima, Kollam, Kolkata, Mumbai, Meghalaya, Mizoram, Sikkim, Nagpur, New Delhi, Pondichery, Pune, Punjab, Thirunananthapuram, Tripura, Wardha


All Trademarks and Brands that appear on the website belong to their respective owners. Alleviare provides only information & in any way, does not lay any claim on these brand names &/or trademarks.